October 11, 2019
Pardis Sabeti and researchers at the Broad Institute have turned a CRISPR RNA-cutting enzyme into an antiviral that can be programmed to detect and destroy RNA-based viruses in human cells. Many of the world's most common or deadly pathogens are RNA-based viruses. The study in Molecular Cell is the first to harness CAS 13 enzyme, or any CRISPR system, as an antiviral in cultured human cells. Broad Institute News